ArticleDisease models & mechanisms2026
Homocysteine and S-adenosyl-L-homocysteine impair development and methylation in yeast and flies.
Article in Disease models & mechanisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
S-adenosyl-L-homocysteine (SAH), the product inhibitor of S-adenosyl-L-methionine-dependent methyltransferases, and its degradation product homocysteine (Hcy) are evolutionarily conserved master regulators of methylation metabolism, which is mediated by more than 200 methyltransferases in humans. Hyperhomocysteinemia (HHcy), characterized by elevated levels of Hcy in the blood, is an independent risk factor for atherosclerosis, a strong predictor of cardiovascular mortality and can cause associated pathology by interfering with methylation-dependent processes. Here, we developed a Drosophila melanogaster fly dietary model of HHcy and a Drosophila melanogaster genetic SAH accumulation model and compared them to corresponding Saccharomyces cerevisiae yeast models to reveal evolutionarily conserved methylation pattern changes responsive to elevation of Hcy levels. Feeding Drosophila an Hcy-containing diet or growing yeast on Hcy-supplemented medium, similarly to genetically blocking SAH degradation, led to SAH accumulation, developmental delay and growth defects. Furthermore, dietary or genetically induced SAH accumulation caused impaired phospholipid and protein methylation in both model organisms. Identification and functional characterization of evolutionarily conserved SAH-dependent methylation targets responsive to elevation of Hcy and/or SAH levels will reveal mechanisms of SAH toxicity in HHcy and help to decipher their role in associated pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.